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shown that ALDH1 positive cells had significantly lower Ki-67
positivity than ALDH1 negative cells (p<0,001). ALDH1 positive
cells never have proliferative level more than 10%.
Nowadays development of metastases often relates to interac-
tion between chemokines and their receptors. In our study we
analyze two receptors: CCR10 and CXCR4 as most known in
literature data.
Investigation of CCR10 and CXCR4 shows, that 77% of colon
cancers have expression of CXCR4 and no one – CCR10. It was
found that low level of proliferation (Ki-67<30%) and expression
of CXCR4 were more often revealed in disseminated cancer (IV
stage) than in localized (II stage), p=0.002. The 5-year relapse- free
survival rate in patients with Ki- 67>70% and CXCR4<30% was
75% and 25%, respectively, with median survival time of 16.5
months. Vice versa cases with CXCR4>70% and Ki-67<30% hadthe
5- year relapse-free survival rates of 32% and in 68%, respectively,
with the median survival time of 7 month. IHC study of MSH2,
MSH6, PMS2, MLH1 shows that at least lack of one marker always
accompanies by microsatellite instability. Mutations of these
markers were accompanied by lack of expression in 100% of
cases. Thus, according to modern classification of colon cancer
grade, we divided 45 cases into low and high grades using only
histological criteria and additionally – IHC investigation of
MSH2, MSH6, PMS2, MLH1. It was shown that in 9% of cases
IHC of these markers prevent incorrect evaluation of cancer
grade. Conclusion: immunohistochemical investigation of CXCR4,
Ki-67, MSH2, MSH6, PMS2, MLH1 may be additional useful prog-
nostic factors for patients with colon adenocarcinoma.
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Melanoma is defined as heterogeneous and complex neoplas-
tic system. Melanoma tumor microenvironment composes of
different cell types including tumor-associated lymphocytes,
macrophages, fibroblasts, etc. These cells may intensify tumor
growth and progression by releasing various active substances.
MicroRNAs are a class of posttranscriptional regulators, which
play an essential role in proliferation, adhesion, motility and
migration of cancer cells. Several studies showed that microRNAs
produced by tumor microenvironment cells could act as
paracrine modulators for modification of cancer cells biological
behavior. For identification of melanoma microenvironment
microRNA profile we performedmicroarray analysis of melanoma
samples (n = 10) obtained from Krasnoyarsk Territory Oncological
Center and macrodissected to separate tumor complexes and
tumor microenvironment.
RNA was extracted from tissue samples by MirVana kit
(Ambion, Life Technologies, Canada) in accordance to manufac-
turer recommendations. The microRNA concentration was
measured by Qubit 2.0 Fluorimeter (Life technologies Holdings
Pte Ltd., USA). miRNA expression profiles were processed by the
Affimetrix microarray system (Affymetrix, Santa Clara, CA,
USA). Expression changes between melanoma and nevi samples
were identified using P-value of 0,05. 2.0-fold difference in either
direction was a minimal fold change expression required. A hier-
archical clustering analysis for differentially expressed miRNAs
was carried out by Transcriptome Analysis Console 2.0.
24 microRNAs were identified with altered expression levels in
melanoma cells as compared to tumor microenvironment cells
including hsa-miR-106a-5p, hsa-miR-3178, hsa-miR-223-3p,
hsa-miR-17-5p, hsa-miR-221-3p, hsa-miR-4745-5p, hsa-miR-107,
hsa-miR-363-3p, hsa-miR-4739, hsa-miR-514b-5p, hsa-miR-3175,
hsa-miR-6805-5p, hsa-miR-6769b-5p. Of 24 miRNAs, 3 were
upregulated in melanoma microenvironment as compared to
melanoma cells, whereas 21 were downregulated. Among these
microRNA, miR-106a-5p was the most downregulated in microen-
vironment, while miR-4433b-5p was found to be the most upreg-
ulated. Of the 24 differentially expressed miRNAs in the tumor
microenvironment, DIANA-miR-path identified 9 miRNAs with
predicted gene targets. MiR-106a-5p as the most upregulated in
melanoma tissue was identified to be involved in MAPK,
TGF-beta signaling pathways regulation. Besides, miR-106a-5p
participates in actin cytoskeleton regulation, adherens junction
and focal adhesion that may correspond to increased motility of
melanoma cells.
MicroRNA profiling may serve as useful tool for preliminary
microRNA search with following their target genes identification
for investigation of epigenetic regulation mechanisms in cancer.
http://dx.doi.org/10.1016/j.ejcsup.2015.08.084
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Background: Glioblastomas (GBL) are most aggressive brain
tumors in adults. They are often radio- and chemotherapy resis-
tant. The standard therapy of GBL includes surgery followed by
radiotherapy with concomitant chemotherapy with temozolo-
mide named temodal (imidazotetrazine derivative). Methylation
of the O6-methylguanine-DNA-methyltransferase (MGMT) gene
promoter is considered as predictor of better outcome of temodal
therapy in comparison with the cases without MGMT promoter
methylation (Stupp et al., 2009). The aim of this study is finding
of additional predictors of temozolomide therapy effectiveness.
Materials and methods: We obtained primary cultures of GBL.
The rate of GBL sensitivity to temozolomide was revealed by
MTT test. Expression of multidrug resistance genes and genes
which mediate temozolomide sensitivity (YB1, MDR1, MRP1,
LRP, BCRP and MGMT) was determined by real time PCR. Protein
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localization and expression was revealed by immunohistochemi-
cal technique.
Results: We developed 14 primary GBL cultures. Staining for
nestin was used for demonstration of neuronal origin of cell
cultures. Analysis of gene expression and the rate of cell prolifer-
ation of the cultures showed that the rate of YB1 gene expression
in slow proliferating cultures is significantly lower than in quickly
proliferating cell populations. Cell cultures differed in temodal
sensitivity 2–2.5-fold. We analyzed whether GBL cell sensitivity
to temodal and the rate of several genes’ expression are
correlated. We did not find the correlation between cell temodal
sensitivity and the rate of MGMT gene expression. These data
are in accordance with some results of another authors (Mullins
et al., 2013; Brennan et al., 2013). However, we revealed positive
correlation of the temodal sensitivity of GBL cultures and
MVP/LRP expression (r = 0.5592, p = 0.04). We found also the trend
to negative correlation between GBL temodal sensitivity and
YB1 gene expression (r = 0.43602, p = 0.02) as well as MDR1
expression (r = 0.4195, p = 0.02).
Conclusion: The rate of temodal sensitivity of GBL primary
cultures is connected with the rate of the expression of
MVP/LRP, YB1 and MDR1genes. It is likely that YB-1 protein affects
temodal sensitivity by influence on DNA reparation. YB1 could
also have an effect on MDR1 expression. MVP/LRP expression is
independent factor of GBL prognosis.
This paper was completed with partial support from the Russian
Foundation for Basic Research – Russia (Grant No. 23-04-40204).
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Malignant tumors consist not only of neoplastic cells, but also
of various normal cells, for example fibroblasts, macrophages or
endothelial cells. These normal cells stand under constant
pressure of transformed cells, regulating their properties and
converting them into tumor-promoting cells. Tumor-stroma
interaction takes place during all stages of carcinogenesis. Notch
activation upon receptor binding with the ligand is a way of direct
intercellular communication during embryo- and histogenesis,
determining various processes like differentiation, proliferation,
etc. It has been previously shown that in tumors this signaling
cascade regulates not only properties of transformed cells, but
also stromal cells activities, i.e. neoangiogenesis. The Notch role
in communication between neoplastic cells and stromal
fibroblasts is underinvestigated.
Cancer-associated stromal fibroblasts (CAFs) are an important
component of tumors secreting growth factors and proteases,
modulating immune reactions and contributing to cancer stem
cells niches formation. CAFs resemble myofibroblasts and
express aSmooth-Muscle Actin (aSMA).
We obtained and characterized cultures of normal mesenchy-
mal cells: a myofibroblasts-like (MF), and fibroblasts-like MC1 and
MC2, differing by Notch1 expression. These cell cultures variously
influenced growth of colon cancer notch- ligand Jagged2-positive
HCT116 xenographs in nude mice. MF cells were characterized by
the strongest while Notch1-deficient MC2 by the weakest
tumor-promoting activity.
MC1 but not MC2 started to express aSMA upon co-cultivation
in vitro with neoplastic HCT116 cells. Such co-cultivation also
lead to Notch activation according to a luciferase reporter. NICD
(Notch Intracellular Domain) expression activated MC1 and
MC2, while Notch1 silencing in MC1 abrogated both HCT116-
mediated activation of the fibroblasts in vitro and their
tumor-promoting activity in vivo.
Notch signaling in mesenchymal cells stimulated TGFb
production that lead to both autocrine and paracrine receptors
stimulation. We believe that this cytokine activates fibroblasts
in our experimental system. We also revealed that this process
was p53-dependent.
So we have shown Notch1 to be involved in tumor-stroma
interaction, particularly its activation leading to fibroblasts
transdifferentiation. Notch1-stimulated fibroblasts are able to
produce TGFb and to promote tumor growth in xenographs. The
tumor-stimulating potency of various fibroblasts in our experi-
mental system depends on their ability to transdifferentiate to
myofibroblasts upon Notch activation.
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The efficiency of endocrine therapy for tumors is limited by
the development of hormone resistance and progression of tumor
cells to hormone-independent phenotype. Among these tumors –
breast cancers, for which hormone therapy is one of the most
common and effective methods of treatment, but only in cases,
when the tumors retain their hormonal dependence. The mecha-
nism of hormonal independence was found to be based on the
fundamental properties of cancer cell including both downregula-
tion of specific hormone receptors, and affecting of intracellular
signalling, particularly – estrogen-independent growth signaling
pathways. However, the role of the intercellular interactions in
the progression of hormonal resistance is still unclear.
We hypothesize, that the formation of the clone of the
hormone-resistant cells in the tumor, and the subsequent com-
mon growth of the hormone-resistant and sensitive cells may
lead to spread the hormonal resistance to the sensitive cells –
as a result of the secretion of the specific factors acting in the
paracrine manner or via the direct cell–cell contacts. Here, using
the estrogen-dependent breast cancer cells MCF-7 and the
resistant subline MCF-7/T developed by long-term cultivation of
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